Want to see ZVSA full AI Analyst Report?
ZyVersa Therapeutics (ZVSA) Income Statement
ZyVersa Therapeutics Income Statement
Last quarter (Q1 2026), ZyVersa Therapeutics's total revenue was $0.00. In Q1, ZyVersa Therapeutics's net income was $-1.79M. See ZyVersa Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ -6.93K | $ -10.40K | $ -10.40K | $ -10.40K | |
| $ 6.84M | $ 9.13M | $ 14.41M | $ 13.82M | $ 7.70M | |
| Depreciation and Amortization | $ 0.00 | $ 6.93K | $ 10.40K | $ 9.87K | $ 10.40K |
| $ -25.29M | $ -9.14B | $ -107.74M | $ -14.43M | $ -7.25M | |
| $ -6.84M | $ -9.14B | $ -14.42M | $ -13.83M | $ -7.70M | |
| $ -18.96M | $ -283.35M | $ -93.33M | $ -1.03M | $ -379.79K | |
| $ -25.80M | $ -9.42B | $ -107.75M | $ -14.87M | $ -8.08M | |
| $ -24.95M | $ -9.41B | $ -98.30M | $ -14.05M | $ -8.08M | |
| Per Share Metrics | |||||
| Basic EPS | $ -4.18 | $ -8.48 | $ -1089.66 | $ -930.25 | $ -173.66 |
| Diluted EPS | $ -4.18 | $ -8.48 | $ -1089.66 | $ -930.25 | $ -173.66 |
| Weighted Average Shares Outstanding | 5.96B | 1.11M | 97.50K | 25.95K | 46.55K |
| Weighted Average Shares Outstanding (Diluted) | 5.96B | 1.11M | 97.50K | 25.95K | 46.55K |
Currency in USD